Intricon Achieves ‘Critical Milestone’ in Clinical Study of Software
Intricon Corporation (NASDAQ: IIN), a joint development manufacturer of micromedical technology for use in interventional, implantable, and body-worn medical devices, announced that it has achieved “a critical milestone in the clinical study of its proprietary software that will allow people to self-fit hearing aids that are sold over-the-counter at retail stores and online.”
Read More